A study published 11 May in the journal Science Translational Medicine, has found a possible cause of severe COVID-19. Many people who become infected are either asymptomatic, or have mild symptoms. The link or cause between what causes a person to develop severe symptoms remains under investigation. This study found those with severe symptoms produced higher amounts of antibodies, but that these antibodies were also aberrant. In those with severe COVID-19, the aberrant antibodies produced a stronger pro-inflammatory response in the immune cells in the lungs compared to those without severe symptoms. This increase in inflammation, sometimes called cytokine storm, causes destruction of the patient’s healthy lung cells as well as attacking the virus. The process leads to the lungs filling with fluid, and problems with clots.
While some medications such as dexamethasone are effective at treating severe COVID-19, they depress the immune system overall. The study found that the drug fostamatinib “ensures the immune cells in the lungs no longer react to the abnormal antibodies, but still react to the virus.”